Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Role of Lysophosphatidylcholine (LPC) in Atherosclerosis.

Role of Lysophosphatidylcholine (LPC) in Atherosclerosis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Role of Lysophosphatidylcholine (LPC) in Atherosclerosis. Abstract Text:

    takayuki matsumotoTakayuki Matsumoto,tsuneo kobayashiTsuneo Kobayashi,katsuo kamataKatsuo Kamata,takayuki matsumotoTakayuki Matsumoto,tsuneo kobayashiTsuneo Kobayashi,katsuo kamataKatsuo Kamata,takayuki matsumotoTakayuki Matsumoto,tsuneo kobayashiTsuneo Kobayashi,katsuo kamataKatsuo Kamata,

    Lysophosphatidylcholine (LPC) is a bioactive proinflammatory lipid generated by pathological activities. LPC is also a major phospholipid component of oxidized low-density lipoprotein (Ox-LDL) and is implicated as a critical factor in the atherogenic activity of Ox-LDL. LPC is believed to play an important role in atherosclerosis and inflammatory diseases by altering various functions in a number of cell-types, including endothelial cells, smooth muscle cells, monocytes, macrophages, and T-cells. LPC activates several second messengers -- including protein kinase C, extracellular-signal-regulated kinases, protein tyrosine kinases, and Ca(2+) -- implicating the engagement of transduction mechanisms in its observed actions. Moreover, recent evidence suggests that in several cell-types, cloned orphan G-protein-coupled receptors may serve as the specific receptors via which LPC modulates second messenger pathways (although LPC may not be a direct ligand of such receptors). In addition, current evidence suggests that LPC impairs the endothelium-dependent relaxations mediated by endothelium-derived relaxing factors and directly modulates contractile responses in vascular smooth muscle. However, despite all this, and although elevated levels of LPC have been linked to the cardiovascular complications associated with atherosclerosis, ischemia, and diabetes, the precise pathophysiological roles played by LPC in several states remain to be established. In this review, we focus in some detail on the entirety of the signal-transduction system for LPC, its pathophysiological implications, and the vascular abnormalities associated with it.

    Role of Lysophosphatidylcholine (LPC) in Atherosclerosis. Publishing Authors By Initials

    t matsumotoT Matsumoto,t kobayashiT Kobayashi,k kamataK Kamata,t matsumotoT Matsumoto,t kobayashiT Kobayashi,k kamataK Kamata,t matsumotoT Matsumoto,t kobayashiT Kobayashi,k kamataK Kamata,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Role of Lysophosphatidylcholine (LPC) in Atherosclerosis. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Current medicinal chemistry

    VOLUME: 14

    Page Numbers: 3209-20

    Journal Abbreviation: Curr. Med. Chem.

    ISSN: 0929-8673

    DAY: 28

    MONTH: 01

    YEAR: 2007

    Role of Lysophosphatidylcholine (LPC) in Atherosclerosis. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9440157

    Role of Lysophosphatidylcholine (LPC) in Atherosclerosis. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Role of Lysophosphatidylcholine (LPC) in Atherosclerosis. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Role of Lysophosphatidylcholine (LPC) in Atherosclerosis.

    AFFILIATION: Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University, Shinagawa-ku, Tokyo 142-8501, Japan. kamata@hoshi.ac.jp.

    Country: Netherlands

    Netherlands Research PublicationNetherlands Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Curr Med Chem

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Role of Lysophosphatidylcholine LPC in Atherosclerosis Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News